Antibacterial drugs and cyclodextrin inclusion complexes: a patent review

References

• Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–655.
   PubMed Web of Science ®Google Scholar
• Vm D, CE K, Kalan L, et al. Antibiotic resistance is ancient. Nature. 2011;477:457–461.
   PubMed Web of Science ®Google Scholar
• World Heath Organization (WHO): Global HIV & AIDS statistics — fact sheet. UNAIDS [Internet]. 2021. [cited 2022 Jun 6]. Available from: https://www.unaids.org/en/resources/fact-sheet
   Google Scholar
• O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistence. 2016;1–35.
   Google Scholar
• Ben Y, Fu C, Hu M, et al. Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: a review. Environ Res. 2019;169:483–493.
   PubMed Web of Science ®Google Scholar
• Yahya NA, Attan N, Wahab RA. An overview of cosmeceutically relevant plant extracts and strategies for extraction of plant-based bioactive compounds. Food Bioprod Process. 2018;112:69–85.
   Web of Science ®Google Scholar
• Ligon BL. Penicillin: its Discovery and Early Development. Semin Pediatr Infect Dis. 2004;15:52–57.
   PubMedGoogle Scholar
• Santos AM, Santos MM, JAC NJ Mapping of New Pharmacological Alternatives in the Face of the Emergence of Antibiotic Resistance in COVID-19 Patents Treated for Opportunistic Respiratory Bacterial Pathogens. Recent advances in anti-infective drug discovery. 2022;17(1): 34–53. DOI:10.2174/1574891X16666220518142347.
   PubMedGoogle Scholar
• Brito RG, Aas A, Quintans JSS, et al. Enhanced analgesic activity by cyclodextrins - a systematic review and meta-analysis. Expert Opin Drug Deliv. 2015;12:1677–1688.
   PubMed Web of Science ®Google Scholar
• Kurkov SV, Loftsson T. Cyclodextrins. Int J Pharm. 2013;453:167–180.
   PubMed Web of Science ®Google Scholar
• Moraes CM, Abrami P, Gonçalves MM, et al. Preparação e caracterização físico- química de complexos de inclusão entre anestésicos locais e hidroxipropil-β-ciclodextrina. Quim Nova. 2007;30:777–784.
   Google Scholar
• Zarandona I, Barba C, Guerrero P Development of chitosan films containing β-cyclodextrin inclusion complex for controlled release of bioactives. Food Hydrocoll. 2020;104. DOI:10.1016/j.foodhyd.2020.105720.
   Web of Science ®Google Scholar
• Aiassa V, Garnero C, Longhi MR. Cyclodextrin multicomponent complexes: pharmaceutical applications. Pharmaceutics. 2021;13(7): 1099. DOI: 10.3390/pharmaceutics13071099.
   PubMed Web of Science ®Google Scholar
• Jambhekar SS, Breen P. Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex. Drug Discov Today. 2016;21:356–362.
   PubMed Web of Science ®Google Scholar
• Le-Deygen IM, Skuredina AA, Uporov IV, et al. Thermodynamics and molecular insight in guest–host complexes of fluoroquinolones with β-cyclodextrin derivatives, as revealed by ATR-FTIR spectroscopy and molecular modeling experiments. Anal Bioanal Chem. 2017;409:6451–6462.
   PubMed Web of Science ®Google Scholar
• Deygen IM, Egorov AM, Kudryashova EV. Structure and stability of fluoroquinolone-(2-hydroxypropyl)-β-cyclodextrin complexes as perspective antituberculosis drugs. Moscow University Chemistry Bulletin. 2016;71:1–6.
   Google Scholar
• Rodriguez-Aller M, Guinchard S, Guillarme D, et al. New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance. Eur J Pharm Biopharm. 2015;95:203–214.
   PubMed Web of Science ®Google Scholar
• Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem. 2004;39:1033–1046.
   Web of Science ®Google Scholar
• Diniz TC, Pinto TCC, Menezes P dos Pet al. Cyclodextrins improving the physicochemical and pharmacological properties of antidepressant drugs: a patent review. Expert Opin Ther Pat. 2018;28(1):81–92. DOI:10.1080/13543776.2017.1384816. Taylor and Francis Ltd.
   PubMed Web of Science ®Google Scholar
• Karam G, Chastre J, Wilcox MH, et al. Antibiotic strategies in the era of multidrug resistance. Crit Care. 2016;20(1):136. DOI:10.1186/s13054-016-1320-7.
   PubMed Web of Science ®Google Scholar
• Lin L, Chen Y, Yan L, Analysis of clinical trials of new drugs in China as of 2019. Drug Discov Today. Elsevier Ltd. 2020;25(12):2080–2088. DOI:10.1016/j.drudis.2020.09.030.
   PubMed Web of Science ®Google Scholar
• Miethke M, Pieroni M, Weber T, et al. Towards the sustainable discovery and development of new antibiotics. Nat Rev Chem. 2021;5:726–749.
   PubMed Web of Science ®Google Scholar
• Cole ST. Who will develop new antibacterial agents? Philos Trans R Soc B. 2014;369:20130430.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO): WHO publishes list of bacteria for which new antibiotics are urgently needed [Internet]. 2017 [cited 2022 May 24]. Available from: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed.
   Google Scholar
• Gutierrez D, Weinstock A, Antharam VC, et al. Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to Candida albicans colonization in the gastrointestinal tract. FEMS Microbiol Ecol. 2020;96(1):187. DOI:10.1093/femsec/fiz187.
   Web of Science ®Google Scholar
• Nguyen HT, Hensel A, Goycoolea FM. Chitosan/cyclodextrin surface-adsorbed naringenin-loaded nanocapsules enhance bacterial quorum quenching and anti-biofilm activities. Colloids Surf B Biointerfaces. 2022;211:112281. DOI:10.1016/j.colsurfb.2021.112281.
   PubMed Web of Science ®Google Scholar
• Breijyeh Z, Jubeh B, Karaman R, et al. Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules. 2020;25(6) :1340. DOI:10.3390/molecules25061340.
   PubMed Web of Science ®Google Scholar
• Serafini MR, Santos VV, Torres BGS, et al. A patent review of antibiofilm fungal drugs (2002-present). Crit Rev Biotechnol. 2021;41:229–248.
   PubMed Web of Science ®Google Scholar
• Santos AM, dos SCC, de Oliveira TB, et al. What’s New in Allergen Immunotherapy Patents? A Review. Crit Rev Ther Drug Carrier Syst. 2021;38:105–125.
   PubMed Web of Science ®Google Scholar
• Vila J, Moreno-Morales J, Ballest E-Delpierre C. Narrative review Current landscape in the discovery of novel antibacterial agents. Clin Microbiol Infect. 2020;26:596.
   PubMed Web of Science ®Google Scholar
• Day DR, Jabaiah S, Jacobs RS, et al. Cyclodextrin formulation of the marine natural product pseudopterosin a uncovers optimal pharmacodynamics in proliferation studies of human umbilical vein endothelial cells. Mar Drugs. 2013;11:3258.
   PubMed Web of Science ®Google Scholar
• Andreadelis I, Chatziathanasiadou ΜV, Ntountaniotis D, et al. Charting the structural and thermodynamic determinants in phenolic acid natural product–cyclodextrin encapsulations. J Biomol Struct Dyn. 2021;39:2642–2658.
   PubMed Web of Science ®Google Scholar
• Tiwari G, Tiwari R, Rai AK. Cyclodextrins in delivery systems: applications. J Pharm Bioallied Sci. 2010;2:72.
   PubMedGoogle Scholar
• Skwarczynski M, Bashiri S, Yuan Y, et al. Antimicrobial activity enhancers: towards smart delivery of antimicrobial agents. Antibiotics. 2022;11(3):412. DOI:10.3390/antibiotics11030412.
   Google Scholar
• Vandera KKA, Picconi P, Valero M, et al. Antibiotic-in-cyclodextrin-in-liposomes: formulation development and interactions with model bacterial membranes. Mol Pharm. 2020;17:2354–2369.
   PubMedGoogle Scholar
• Aleem O, Kuchekar B, Pore Y, et al. Effect of β-cyclodextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. J Pharm Biomed Anal. 2008;47(3): 535–540. DOI:10.1016/j.jpba.2008.02.006.
   PubMed Web of Science ®Google Scholar
• Silva Pereira RL, Campina FF, et al. Antibacterial and modulatory activities of β-cyclodextrin complexed with (+)-β-citronellol against multidrug-resistant strains.Microb Pathog. 2021;156:104928. DOI:10.1016/j.micpath.2021.104928.
   PubMed Web of Science ®Google Scholar
• Durojaiye AB, Clarke JRD, Stamatiades GA, et al. Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies. J Biomol Struct Dyn. 2020;39:1.
   Web of Science ®Google Scholar
• Ren YG. Medicine composition containing ceftin cyclodextrin clathrate, and its preparing method. CN101002782A . 2007.
   Google Scholar
• Haide C, Xuefeng D. inventors; Xuefeng Deng, assignee. In: Cefuroxime axetil composite medicine. China patent CN. 2010 Oct. Vol. 101849948A. p. 06.
   Google Scholar
• Mizera M, Szymanowska D, Stasiłowicz A, et al. Computer-aided design of cefuroxime axetil/cyclodextrin system with enhanced solubility and antimicrobial activity. Biomolecules. 2020;10(1):24. DOI:10.3390/biom10010024.
   Web of Science ®Google Scholar
• Stafylis C, Keith K, Mehta S, et al. Clinical efficacy of cefixime for the treatment of early syphilis. Clin Infect Dis. 2021;73:907.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Thomas T, Howe D, et al. Cefdinir and β-lactamase inhibitor independent efficacy against mycobacterium tuberculosis. Front Pharmacol. 2021;12:677005.
   PubMed Web of Science ®Google Scholar
• Dey KK, Ghosh M. Study of the structure and dynamics at various parts of the antibacterial drug molecule cefpodoxime proxetil. Solid State Nucl Magn Reson. 2021;115:101752. DOI:10.1016/j.ssnmr.2021.101752.
   PubMed Web of Science ®Google Scholar
• Yong R, Jianfeng G, Binbin H, et al. 2008Sep inventors; Univ Nanjing Normal, assignee, Medicinal composition containing cefpodoxime proxetil cyclodextrin inclusion compound and preparation thereof. China patent CN Vol. 101264087A, 17.
   Google Scholar
• Yong R, Jianfeng G, Binbin H, et al., inventors; Univ Nanjing Normal, assignee. Medical composition containing cyclodextrin inclusion compound of cefdinir and its preparation method. World Organization patent WO 2008110079A1. 2008 Sep 18.
   Google Scholar
• Yong R, Jianfeng G, Binbin H, et al., inventors; Univ Nanjing Normal, assignee. Medical composition containing cyclodextrin inclusion compound of cefixime and its preparation method. World Organization patent WO 2008110080A1. 2008 Sep 18.
   Google Scholar
• Wang L, Wang J, Gu J. inventors; Hainan Wei Kang Pharmaceutical Qianshan CO LTD, assignee. In: Cefpodoxime proxetil composition freeze-dried powder injection for injection. China patent CN. 2014 Feb;Vol. 103550169A. p. 05.
   Google Scholar
• Li Q, Yang L. inventors. In: Youcare pharmaceutical group, assignee. cefathiamidine composition. China patent CN. 2015 Apr. Vol. 104524585A. p. 22.
   Google Scholar
• Firth A, Prathapan P. Azithromycin: the first broad-spectrum therapeutic. Eur J Med Chem. 2020;207:112739.
   PubMed Web of Science ®Google Scholar
• Malanga M, Szemán J, É F, et al. “Back to the future”: a new look at hydroxypropyl beta-cyclodextrins. J Pharm Sci. 2016;105:2921–2931.
   PubMed Web of Science ®Google Scholar
• Pilo P, Frey J. Pathogenicity, population genetics and dissemination of Bacillus anthracis. Infect Genet Evol. 2018;64:115–125.
   PubMed Web of Science ®Google Scholar
• Chepur SV, Bykov VN, Tjunin MA, et al., inventors. Bykov VN, Tjunin MA, assignees. Pharmaceutical composition with antibacterial activity. Russia patent RU 2435583C1. 2011 Dec 10.
   Google Scholar
• Zhang D, Sun F, Wang Y, et al. 2018Dec inventors, Univ army medical, assignee. Active oxygen responsive moxifloxacin nano preparation as well as preparation method thereof. China patent CN Vol. 109010311A, 18.
   Google Scholar
• Ding Y, Pang Y, Vara Prasad CVNS, et al. Formation of inclusion complex of enrofloxacin with 2-hydroxypropyl-β-cyclodextrin. Drug Deliv. 2020;27:334.
   PubMed Web of Science ®Google Scholar
• Jia Y, Zhao L. The antibacterial activity of fluoroquinolone derivatives: an update (2018–2021), Eur J Med Chem, 2021;224:113741. Elsevier Masson
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shao X. inventors. In: Univ Northwestern, assignee. Application of nano-ciprofloxacin particles in inhibiting formation of pseudomonas aeruginosa biofilm. China patent CN. 2017 Mar. Vol. 106474079A. p. 08.
   Google Scholar
• Zhang GF, Liu X, Zhang S , et al. Ciprofloxacin derivatives and their antibacterial activities. Eur J Med Chem. Elsevier Masson SAS. 2018;146:599–612. DOI:10.1016/j.ejmech.2018.01.078.
   PubMed Web of Science ®Google Scholar
• Crabol Y, Catherinot E, Veziris N, et al. Rifabutin: where do we stand in 2016? J Antimicrob Chemother. 2016;71:1759–1771.
   PubMed Web of Science ®Google Scholar
• Gelperina SE, Maximenko OO, Vanchugova LV, et al., inventors. Nanosystem LTD, assignee. Pharmaceutical composition based on cyclodextrin nanoparticles comprising rifabutin, method for preparing thereof, method for treating mikobacteriosis and helicobacterial infection (variants). Russia patent EA 016410B1. 2012 Apr 30.
   Google Scholar
• Falagas ME, Kyriakidou M, Voulgaris GL, et al. Clinical use of intravenous polymyxin B for the treatment of patients with multidrug-resistant Gram-negative bacterial infections: an evaluation of the current evidence. J Glob Antimicrob Resist. 2021;24:342–359.
   PubMed Web of Science ®Google Scholar
• Yamamura H, Miyagawa A. inventors. In: Nagoya Inst Technology, assignee. Cyclodextrin derivative, antibacterial agent using the same, and antibacterial activity potentiator using the same. Japan patent JP. 2013 Sep. Vol. 2013177477A. p. 09.
   Google Scholar
• Wang J, Jin Z, Xu X. Gamma-cyclodextrin on enhancement of water solubility and store stability of nystatin. J Incl Phenom Macrocyclic Chem. 2014;78:145–150.
   Web of Science ®Google Scholar
• Yamamura H, Hagiwara T, Hayashi Y, et al. Antibacterial activity of membrane-permeabilizing bactericidal cyclodextrin derivatives. ACS Omega. 2021;6:31831–31842.
   PubMed Web of Science ®Google Scholar
• Barenholz Y, Goldblum A, Cern A. inventors. In: Yissum Res Dev CO, assignee. Liposomal mupirocin. China patent CN. 2017 May. Vol. 106659795A. p. 10.
   Google Scholar
• Amar MJA, Kaler M, Courville AB, et al. Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids. Lipids Health Dis. 2016;15:115.
   PubMed Web of Science ®Google Scholar
• Fu L, Zhang T, Wang F, et al. inventors. In: Zhejiang reachall pharmaceutical CO LTD, assignee. Compound ointment preparation and preparation method thereof. China patent CN. 2018 Aug. Vol. 108434437A. 24.
   Google Scholar
• Wüpper S, Lüersen K, Cyclodextrins RG, et al. Plant bioactives—a nutritional perspective. Biomolecules. 2021;11:1–21.
   Web of Science ®Google Scholar
• Parvez MK, Herb-DRUG Interactions RV. Hepatotoxicity. Curr Drug Metab. 2019;20:275–282.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Takahashi M. inventors. Oji Paper CO, Eishogen KK, assignee. method for producing extract from eucalyptus. Japan Patent JP. 2001 Dec;2001348307A:18.
   Google Scholar
• Terao K, Jo A, Nakata D. inventors. Manuka health new Zealand LTD, assignee. Antimicrobial compositions. Australia patent AU 2015258179A1. 2015 Dec 13.
   Google Scholar
• Johnston M, McBride M, Dahiya D, et al. Antibacterial activity of Manuka honey and its components: an overview. AIMS Microbiol. 2018;4:655.
   PubMed Web of Science ®Google Scholar
• Gao G. inventor. Iangxi Zhongtain Medical Biolog CO LTD, assignee. Ginger and garlic enteric-coated tablet and preparation method thereof. China patent CN. 2013 Mar. 102961713A. 13.
   Google Scholar
• Zhao C, Zhou Y, Zhou Y, et al., inventors. Guizhou Univ Of Traditional Chinese Medicine, assignee. Ointment containing litsea cubeba volatile oil and preparing method and application of ointment. China patent CN. 2019 Sep. 110269884A. 24.
   Google Scholar
• Chen A, Feng B, Wu X. inventors. Xinjiang Shengming Heli High Tech CO LTD, assignee. Purified plains coreopsis flavone tablet and preparation method thereof. China patent CN. 2014 Sep. 104013659A. 03.
   Google Scholar
• Liu N, Zhao Y, Che Y. inventors. In: Univ yunnan traditional Chinese Medicine, assignee. Zanthoxylum bungeanum Maxim essential oil inclusion compound oral tablet and preparation method thereof. CN. 2020 Sep. Vol. 111643567A. p. 11.
   Google Scholar
• Chen C, Wang J, Tang J, et al., inventors. Chongqing Newfine Biology Technology CO LTD, assignee. Preparation method of Zingiber corallinum hance essential oil/hydroxypropyl-beta-cyclodextrin clathrate and preparation method of Zingiber corallinum hance essential oil/hydroxypropyl-beta-cyclodextrin clathrate injection. China patent CN. 2013 Jan. 102847102A. 02.
   Google Scholar
• Ping Z, inventor. Ping Z, assignee. Freeze dried injection with heat-clearing, antibiosis and antiviral function and preparation method thereof. China patent CN 100367979C. 2008 Feb 13.
   Google Scholar
• Wenrong H. inventor. Wenrong H, assignee. Method for preparing houttuynia freeze-dried powder injection. China patent CN. 2009 May. 100490849C. 27.
   Google Scholar
• Wang K, Feng X, Chai L, et al. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. Taylor and Francis Ltd. 2017;49(2):139–157. DOI:10.1080/03602532.2017.1306544.
   PubMed Web of Science ®Google Scholar
• Yu M, Wang S. inventors. Univ Chongqing Medical, assignee. Berberine-carried carboxymethyl Beta-cyclodextrin functional montmorillonite drug releasing system. China patent CN. 2017 Aug. 107029249A. 11.
   Google Scholar
• Pu H, Tang P, Zhao L, et al. Preparation of a carboxymethyl β-cyclodextrin polymer and its rapid adsorption performance for basic fuchsin. RSC Adv. 2020;10:20905.
   PubMed Web of Science ®Google Scholar
• Ding W, Zhang Z, Wang Y, et al. inventors. Univ Guangxi Chinese Medicine, assignee. Baicalein nano preparation as well as preparation method and application thereof. China patent CN. 2021 Oct. 113546072A. 26.
   Google Scholar
• Paczkowska‐walendowska M, Rosiak N, Tykarska E, et al. Tedizolid-cyclodextrin system as delayed-release drug delivery with antibacterial activity. Int J Mol Sci. 2021;22:1–15.
   Web of Science ®Google Scholar
• Gallopo AR, Lynch DM. inventors. Warner Lambert CO, assignee. Cyclodextrin complexes of bis-biguanido hexane compounds. European Patent Organization patent EP 0306455A1. 1989 Mar 08.
   Google Scholar
• Takashi K, Maeda A, Fujita I, et al., inventors. Nippo Kagaku Kk, Nitto Serofuan Kk, Yamasan Kk, Mizusawa Industrial Chem, assignees. New inclusion compound, its use and resin composition. Japan patent JPH. 1998 Feb. 1045609A. 17.
   Google Scholar
• Nogami H, Nakahara K, Suzuki H, et al., inventors. Lintec Corp, Nippo Kagaku KK, assignee. Antibacterial adhesive product. Japan patent JP. 2010 Sep. 2010215925A. 30.
   Google Scholar
• Machida H, Nakajima H. inventors. Arigen pharmaceuticals Inc, assignee. Injectable formulation of antibiotic and solution for intravenous administration thereof. Canada patent CA 2656604A1. 2008 Jan 03.
   Google Scholar
• Nagai S, Riko K. Nikawa H. inventors. Jex Co Ltd, Univ Hiroshima Nat Univ Corp, assignee. Silicon-containing compound aqueous solution and antibacterial/antiviral agent including said solution. China patent CN. 2015 Jul. 104754944A. 01.
   Google Scholar
• Fushimi M, Terao K, Ishida Y, et al., inventors. Mitsui Chemicals Inc, Cyclochem BIO CO LTD, assignees. Aqueous solution and antibacterial agent. Japan patent JP. 2020 Dec. 2020196683A. 10.
   Google Scholar
• Omar J, Ponsford D, Dreiss CA, et al. Front Cover: supramolecular hydrogels: design strategies and contemporary biomedical applications (Chem. Asian J. 9/2022) [Internet]. Chem Asian J. 2022;17:e202200331.
   Web of Science ®Google Scholar
• Dong M, Xi X, Liming Z, et al. inventors. Univ Sun Yat Sen, assignee. Antibacterial supermolecule aquogel and preparation method and application thereof. XhinaChina patent CN. 2009 Oct. 101564400A. 28.
   Google Scholar
• Zhou J, Chen X, Yu J, et al., inventors. 3RD Xiangya hospital central South Univ, assignee. Technology of modifying nano titanium dioxide by non-covalent bond coating. China patent CN 106797954A. 2017 Jun 6.
   Google Scholar
• Zhang J, Wu C, Wang Z, et al., inventors. Shenzhen Huangjia Biotechnology CO LTD, assignee. Preparation method and application of salicylic acid ionic salt/eutectic cyclodextrin inclusion compound liposome. China patent CN. 2022 Apr. 114306123A. 12.
   Google Scholar
• Wu C, Zhang J, Wang Z, et al., inventors. Shenzhen Shine Biotechnology CO LTD, assignee. Preparation method and application of azelaic acid ionic salt/eutectic cyclodextrin inclusion compound liposome. China patent CN. 2022 Feb. 114028262A. 11.
   Google Scholar
• Bulbake U, Doppalapudi S, Kommineni N , et al. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics. 2017;9(2):12.
   PubMed Web of Science ®Google Scholar
• Menezes P, dos P, Andrade T de A, et al. Advances of nanosystems containing cyclodextrins and their applications in pharmaceuticals. Int J Pharm. 2019;559:312–328. Elsevier B.V.
   PubMed Web of Science ®Google Scholar
• Zucca M, Savoia D. The post-antibiotic era: promising developments in the therapy of infectious diseases [Internet]. Master Publishing Group. Int J Biomed Sci. 2010:77–86.
   PubMedGoogle Scholar
• Felden B, Cattoira V. Bacterial Adaptation to Antibiotics through Regulatory RNAs. Antimicrob Agents Chemother. 2018;62(5):e02503–17 .
   Web of Science ®Google Scholar
• Mühlberg E, Umstätter F, Kleist C , et al. Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria. Can J Microbiol. Canadian Science Publishing. 2020;66(1):11–16. DOI:10.1139/cjm-2019-0309.
   PubMed Web of Science ®Google Scholar
• Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66.
   PubMed Web of Science ®Google Scholar
• Surette MD, Wright GD. Lessons from the environmental antibiotic resistome. Annu Rev Microbiol. 2017;71:309–329.
   PubMed Web of Science ®Google Scholar
• Coates AR, Halls G, Hu Y. Novel classes of antibiotics or more of the same?. Br J Pharmacol. 2011;163(1): 184–194. DOI:10.1111/j.1476-5381.2011.01250.x.
   PubMed Web of Science ®Google Scholar
• Bravo A, Ruiz-cruz S, Alkorta I, et al. When humans met superbugs : strategies to tackle bacterial resistances to antibiotics. BioMol Concepts. 2018;9:216–226.
   PubMedGoogle Scholar
• Cal PMSD, Matos MJ, Bernardes GJL. Trends in therapeutic drug conjugates for bacterial diseases: a patent review. Expert Opin Ther Pat. 2017;27:179–189.
   PubMed Web of Science ®Google Scholar
• Jansook P, Ogawa N, Loftsson T. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications. Int J Pharm. 2018;535:272–284.
   PubMed Web of Science ®Google Scholar
• Martins LNSB, Venceslau AFA, Brandão RM, et al. Antibacterial and antifungal activities and toxicity of the essential oil from callistemon viminalis complexed with β-cyclodextrin. Curr Microbiol. 2021;78:2251–2258.
   PubMed Web of Science ®Google Scholar
• Rakmai J, Cheirsilp B, Mejuto JC, et al. Antioxidant and antimicrobial properties of encapsulated guava leaf oil in hydroxypropyl-beta-cyclodextrin. Ind Crops Prod. 2018;111:219–225.
   Web of Science ®Google Scholar
• Gong L, Li T, Chen F, et al. An inclusion complex of eugenol into β-cyclodextrin: preparation, and physicochemical and antifungal characterization. Food Chem. 2016;196:324–330.
   PubMed Web of Science ®Google Scholar
• Li JF, Zhang JX, Wang ZG, et al. Identification of a cyclodextrin inclusion complex of antimicrobial peptide CM4 and its antimicrobial activity. Food Chem. 2017;221:296–301.
   PubMed Web of Science ®Google Scholar
• Rincón-López J, Almanza-Arjona YC, Riascos AP, et al. When cyclodextrins met data science: unveiling their pharmaceutical applications through network science and text-mining. Pharmaceutics. 2021;13:1297.
   PubMed Web of Science ®Google Scholar